fulvestrant has been researched along with etomidate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Li, C; Lu, X; Sun, J; Yang, C | 1 |
1 review(s) available for fulvestrant and etomidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fulvestrant and etomidate
| Article | Year |
|---|---|
Role of estradiol in mediation of etomidate-caused seizure-like activity in neonatal rats.
Topics: Anesthetics, Intravenous; Animals; Brain; Bumetanide; Electroencephalography; Estradiol; Estrogen Receptor Antagonists; Etomidate; Female; Fulvestrant; Male; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Seizures; Sex Factors; Sodium Potassium Chloride Symporter Inhibitors | 2019 |